DOTA Scan

A DOTA scan, or Gallium-68 DOTATATE PET-CT, is a specialised nuclear imaging test used to detect neuroendocrine tumours by targeting somatostatin receptors that these tumours often overexpress. It offers far greater sensitivity than conventional imaging for finding small or metastatic neuroendocrine lesions throughout the body. The scan is also used to determine eligibility for peptide receptor radionuclide therapy, a targeted treatment for these cancers. It combines PET functional imaging with CT anatomical detail for precise tumour localisation.

DOTA Scan is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Nuclear Medicine specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 2-4 hours. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes There is no recovery period required and patients can resume normal activities immediately after the scan. Increased water intake helps flush residual tracer from the body over the following day. Results are reviewed by an oncology multidisciplinary team to plan further treatment.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

DOTA Scan has a documented success rate of Highly sensitive for neuroendocrine tumours at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.